Tag:

Lilly's rheumatoid arthritis drug cuts COVID-19 deaths in trial,…

Arthritis drug improves survival odds for COVID-19 patients treated with remdesivir by 35%, NIH study finds An NIH trial tested a combination of Eli Lilly’s arthritis drug, barcitinib, and the antiviral  remdesivir to treat COVID-19  Overall, those who got both drugs were 35% more likely to survive than those given remdesivir alone  People on supplemental

Calling All Blood Donors …

MONDAY, Jan. 14, 2019 — The holidays, winter weather and the flu season have all prompted a blood shortage, the American Red Cross warns. The organization said Monday it had about 27,000 fewer blood and platelet donations than needed over Christmas and New Year’s. People nationwide, especially those with type O blood, are urged to